These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study. Janssens GO; Gidding CE; Van Lindert EJ; Oldenburger FR; Erasmus CE; Schouten-Meeteren AY; Kaanders JH Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):722-6. PubMed ID: 18990510 [TBL] [Abstract][Full Text] [Related]
3. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497 [TBL] [Abstract][Full Text] [Related]
4. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Bernier-Chastagner V; Grill J; Doz F; Bracard S; Gentet JC; Marie-Cardine A; Luporsi E; Margueritte G; Lejars O; Laithier V; Mechinaud F; Millot F; Kalifa C; Chastagner P Cancer; 2005 Dec; 104(12):2792-7. PubMed ID: 16265674 [TBL] [Abstract][Full Text] [Related]
5. Hypofractionated Radiotherapy for Children With Diffuse Intrinsic Pontine Gliomas. Hankinson TC; Patibandla MR; Green A; Hemenway M; Foreman N; Handler M; Liu AK Pediatr Blood Cancer; 2016 Apr; 63(4):716-8. PubMed ID: 26544789 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy. Combs SE; Steck I; Schulz-Ertner D; Welzel T; Kulozik AE; Behnisch W; Huber PE; Debus J Radiother Oncol; 2009 Apr; 91(1):60-6. PubMed ID: 19285356 [TBL] [Abstract][Full Text] [Related]
8. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study. Korones DN; Fisher PG; Kretschmar C; Zhou T; Chen Z; Kepner J; Freeman C Pediatr Blood Cancer; 2008 Feb; 50(2):227-30. PubMed ID: 17278121 [TBL] [Abstract][Full Text] [Related]
9. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma. Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716 [TBL] [Abstract][Full Text] [Related]
10. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature. Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898 [TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience. Negretti L; Bouchireb K; Levy-Piedbois C; Habrand JL; Dhermain F; Kalifa C; Grill J; Dufour C J Neurooncol; 2011 Sep; 104(3):773-7. PubMed ID: 21327862 [TBL] [Abstract][Full Text] [Related]
14. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands. Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089 [TBL] [Abstract][Full Text] [Related]
15. Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Broniscer A; Laningham FH; Kocak M; Krasin MJ; Fouladi M; Merchant TE; Kun LE; Boyett JM; Gajjar A Cancer; 2006 Mar; 106(6):1364-71. PubMed ID: 16463390 [TBL] [Abstract][Full Text] [Related]
16. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas. Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987 [TBL] [Abstract][Full Text] [Related]
17. Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study. Bradley KA; Zhou T; McNall-Knapp RY; Jakacki RI; Levy AS; Vezina G; Pollack IF Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e55-60. PubMed ID: 23092726 [TBL] [Abstract][Full Text] [Related]
19. Role of early postradiation magnetic resonance imaging scans in children with diffuse intrinsic pontine glioma. Ko C; Kaushal A; Hammoud DA; Steffen-Smith EA; Bent R; Citrin D; Camphausen K; Warren KE Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1252-1256. PubMed ID: 22280788 [TBL] [Abstract][Full Text] [Related]
20. Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma. Porkholm M; Valanne L; Lönnqvist T; Holm S; Lannering B; Riikonen P; Wojcik D; Sehested A; Clausen N; Harila-Saari A; Schomerus E; Thorarinsdottir HK; Lähteenmäki P; Arola M; Thomassen H; Saarinen-Pihkala UM; Kivivuori SM Pediatr Blood Cancer; 2014 Sep; 61(9):1603-9. PubMed ID: 24692119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]